Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GRM4 | Q14833 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19728786 | 0.82 | — | — | |
| SCHEMBL879088 | 0.82 | GRM4 (0.33) | GRM4 | |
| SCHEMBL21917242 | 0.78 | GRM4 (0.31) | GRM4 | |
| SCHEMBL21579355 | 0.78 | ALDH1A1 (0.45) | — | |
| SCHEMBL19772674 | 0.78 | GRM4 (0.31) | GRM4 | |
| SCHEMBL24906756 | 0.78 | GRM4 (0.31) | GRM4 | |
| SCHEMBL20881890 | 0.76 | CYP2D6 (0.30) | GRM4 | |
| SCHEMBL805401 | 0.76 | ALDH1A1 (0.38) | GRM4 | |
| SCHEMBL18583366 | 0.76 | GRM4 (0.30) | GRM4 | |
| SCHEMBL12523114 | 0.76 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230295180-A1 | PROTEIN DEGRADERS AND USES THEREOF | KYMERA THERAPEUTICS, INC. | 2023-09-21 | — | — | US | disclosed |
| WO-2022001428-A1 | NEGATIVE POLE PIECE AND SECONDARY BATTERY CONMPRISING NEGATIVE POLE PIECE | 珠海冠宇电池股份有限公司 | 2022-01-06 | — | — | WO | disclosed |
| WO-2021041710-A9 | SYSTEMS AND METHODS FOR PERFORMING ANTIMICROBIAL SUSCEPTIBILITY TESTING | SeLux Diagnostics, Inc. (US) | 2021-11-11 | — | — | WO | disclosed |
| EP-3845663-A1 | METHODS FOR RAPID ANTIMICROBIAL SUSCEPTIBILITY TESTING | Selux Diagnostics Inc. (US) | 2021-07-07 | — | — | EP | disclosed |
| WO-2021041710-A1 | SYSTEMS AND METHODS FOR PERFORMING ANTIMICROBIAL SUSCEPTIBILITY TESTING | SeLux Diagnostics, Inc. (US) | 2021-03-04 | — | — | WO | disclosed |
| US-10040874-B2 | Multifunctional and multicoordinating amphiphilic polymer ligands for interfacing semiconducting, magnetic, and metallic nanocrystals with biological systems | The Florida State University Research Foundation, Inc. (US) | 2018-08-07 | — | — | US | disclosed |
| US-9790329-B2 | Photoligation of an amphiphilic polymer with mixed coordination provides compact and reactive quantum dots | The Florida State University Research Foundation, Inc. (US) | 2017-10-17 | — | — | US | disclosed |
| WO-2017127684-A1 | METHODS FOR RAPID ANTIMICROBIAL SUSCEPTIBILITY TESTING | SeLux Diagnostics, Inc. (US) | 2017-07-27 | — | — | WO | disclosed |
| US-20170058056-A1 | MULTIFUNCTIONAL AND MULTICOORDINATING AMPHIPHILIC POLYMER LIGANDS FOR INTERFACING SEMICONDUCTING, MAGNETIC, AND METALLIC NANOCRYSTALS WITH BIOLOGICAL SYSTEMS | The Florida State University Research Foundation, Inc. | 2017-03-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230295180-A1 | PROTEIN DEGRADERS AND USES THEREOF | MDM2, CUL1, PSMG3 | GRM4 4487/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.